Overexpression of miRNA-433-5p protects acute spinal cord injury through activating MAPK1.

OBJECTIVE The aim of this study was to clarify the role of microRNA-433-5p (miRNA-433-5p) in influencing pathological lesions following acute spinal cord injury (SCI) by targeting mitogen-activated protein kinase 1 (MAPK1). PATIENTS AND METHODS SCI model was successfully established in mice by performing hitting injury procedures. Serum levels of miRNA-433-5p and MAPK1 in SCI patients and mice were determined. Grip strengths of both forelimbs in SCI mice and controls were determined. Dual-Luciferase reporter gene assay was applied to verify the binding relation between miRNA-433-5p and MAPK1. After overexpression of miRNA-433-5p and MAPK1 in vivo, the grip strength changes in SCI mice were assessed. Furthermore, the protein level of inflammatory factor iNOS in 293T cells influenced by miRNA-433-5p and MAPK1 was detected by Western blot. RESULTS MiRNA-433-5p was significantly downregulated in the serum of SCI patients and mice, whereas MAPK1 was up-regulated. Grip strengths of SCI mice were significantly lower than those of controls at different postoperative time points. However, this could be markedly reversed by the in vivo overexpression of miRNA-433-5p. Western blot indicated that the protein level of iNOS was remarkably downregulated in 293T cells overexpressing miRNA-433-5p. MAPK1 was confirmed as the target of miRNA-433-5p, whose expression level was negatively regulated by miRNA-433-5p. Importantly, MAPK1 partially reversed the protective role of miRNA-433-5p in grip strength of SCI mice and inflammatory response at post-SCI. CONCLUSIONS Overexpression of miRNA-433-5p protects SCI-induced motor dysfunction and inflammatory response by targeting MAPK1.

[1]  X-G Zhang,et al.  MicroRNA-490-3p inhibits inflammation and apoptosis induced by spinal cord injury via targeting MK2. , 2018, European review for medical and pharmacological sciences.

[2]  A. Rabinstein,et al.  Traumatic Spinal Cord Injury , 2018, Continuum.

[3]  Shuanke Wang,et al.  Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway , 2018, Oncology research.

[4]  Weimin Fan,et al.  A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance , 2017, Cell Death and Differentiation.

[5]  N. Theodore,et al.  The Role of microRNA Markers in the Diagnosis, Treatment, and Outcome Prediction of Spinal Cord Injury , 2016, Front. Surg..

[6]  N. Zhang,et al.  miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer , 2016, Oncology letters.

[7]  Jianzhong Hu,et al.  Tetramethylpyrazine enhances functional recovery after contusion spinal cord injury by modulation of MicroRNA-21, FasL, PDCD4 and PTEN expression , 2016, Brain Research.

[8]  Jianquan Hou,et al.  MicroRNA‑335 inhibits bladder cancer cell growth and migration by targeting mitogen‑activated protein kinase 1. , 2016, Molecular medicine reports.

[9]  Xiao-Wen Li,et al.  Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition, invasion and metastasis. , 2015, Asian Pacific journal of tropical medicine.

[10]  G. Ju,et al.  Loss of microRNA-124 expression in neurons in the peri-lesion area in mice with spinal cord injury , 2015, Neural regeneration research.

[11]  Gregory D Ayers,et al.  Traumatic spinal cord injury in the United States, 1993-2012. , 2015, JAMA.

[12]  H. Ichijo,et al.  In vivo gene manipulation reveals the impact of stress-responsive MAPK pathways on tumor progression , 2015, Cancer science.

[13]  B. Viollet,et al.  AMPK Suppresses Vascular Inflammation In Vivo by Inhibiting Signal Transducer and Activator of Transcription-1 , 2015, Diabetes.

[14]  Zhe-yu Chen,et al.  microRNAs in Spinal Cord Injury: Potential Roles and Therapeutic Implications , 2014, International journal of biological sciences.

[15]  W. Gan,et al.  Two-Photon-Excited Fluorescence Microscopy as a Tool to Investigate the Efficacy of Methylprednisolone in a Mouse Spinal Cord Injury Model , 2014, Spine.

[16]  J. Kessler,et al.  The emerging roles of microRNAs in CNS injuries , 2013, Nature Reviews Neurology.

[17]  M Fitzharris,et al.  The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate , 2013, Spinal Cord.

[18]  W. Tourtellotte,et al.  microRNA-21 Regulates Astrocytic Response Following Spinal Cord Injury , 2012, The Journal of Neuroscience.

[19]  J. Yang,et al.  Analysis of the causes and types of traumatic spinal cord injury based on 561 cases in China from 2001 to 2010 , 2012, Spinal Cord.

[20]  Francisco J. Esteban,et al.  MicroRNA Dysregulation in the Spinal Cord following Traumatic Injury , 2012, PloS one.

[21]  Xiao-Ming Xu,et al.  MicroRNA in central nervous system trauma and degenerative disorders. , 2011, Physiological genomics.

[22]  D. Tate,et al.  263 BLADDER MANAGEMENT METHODS AFTER TRAUMATIC SPINAL CORD INJURY IN THE UNITED STATES , 2010 .

[23]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[24]  Xiao-Ming Xu,et al.  Altered microRNA expression following traumatic spinal cord injury , 2009, Experimental Neurology.

[25]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.